EU HTA Regulation: Industry’s Missed Opportunity & The PICO Process

Pharmaceutical companies missed a big opportunity to help shape the scoping process for the forthcoming EU-level joint clinical assessments, but they can still contribute to how the process develops, according to Niklas Hedberg, formerly chair of the recently concluded European Network for Health Technology Assessments.